Literature DB >> 29532749

Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy.

Ana Claudia Pompeu Raminelli1, Valeria Romero2, Mohammad H Semreen3,4, Gislaine Ricci Leonardi1,2,5.   

Abstract

BACKGROUND: The clinical efficacy of the topical tretinoin is widely studied and has been well established for many therapeutic interventions, among some, photoaging, acne, and melasma. However, the side effects, mainly cutaneous irritation, erythema, xerosis and peeling, remain major obstacle to the patient compliance. Besides, the insight regarding the drug delivery profile is essential to understand the therapeutic action of the drug.
METHODS: Through bibliographic research in databases we highlight further advances and an update on tretinoin delivery systems such as liposomes, niosomes, solid lipid nanoparticles, nanostructured lipid carriers, cyclodextrins, nanostructured polymers and other technological systems that reduce its side effects and improve the permeation profile to potentiate efficacy and drug safety on the skin.
RESULTS: Pharmaceutical preparations were developed and evaluated for permeability in in vitro models using pig ear, snake, mouse and human skin, and potential for irritation was also verified using release systems for tretinoin and compared to available commercial formulations. Overall results indicated the composition, charge and size of the system influences the tretinoin delivery, modulating the type of release and its retention. Small unilamellar vesicles promoted greater cutaneous delivery of tretinoin. Negative charge, for both liposomes and niosomes, can improve pig skin hydration as well as the tretinoin retention. The quantity of solid lipids and the type of oil used in the composition of solid lipid nanoparticles and nanostructured lipid carriers affected percutaneous drug delivery.
CONCLUSION: As evident from the literature, the tretinoin technological delivery systems consist an innovative and potential management for increasing the patient compliance presenting safety and efficacy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Tretinoin; in vitro permeation; nanotechnology; side effects; topical drug delivery; tretinoin release.

Mesh:

Substances:

Year:  2018        PMID: 29532749     DOI: 10.2174/0929867325666180313110917

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

1.  Microsponge based gel as a simple and valuable strategy for formulating and releasing Tazarotene in a controlled manner.

Authors:  Alaa Khattab; Abdulhakim Nattouf
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

Review 2.  Use of Retinoids in Topical Antiaging Treatments: A Focused Review of Clinical Evidence for Conventional and Nanoformulations.

Authors:  Daniela Milosheska; Robert Roškar
Journal:  Adv Ther       Date:  2022-10-11       Impact factor: 4.070

Review 3.  Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes.

Authors:  Lawrence J Green; Edward Lain; Thomas Prunty; Robert Rhoades
Journal:  J Clin Aesthet Dermatol       Date:  2022-05

4.  Converting Tretinoin into Ionic Liquids for Improving Aqueous Solubility and Permeability across Skin.

Authors:  Xiying Wu; Jingjing Xuan; Qin Yu; Wei Wu; Yi Lu; Quangang Zhu; Zhongjian Chen; Jianping Qi
Journal:  Pharm Res       Date:  2022-03-29       Impact factor: 4.580

Review 5.  Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems.

Authors:  Gemma Latter; Jeffrey E Grice; Yousuf Mohammed; Michael S Roberts; Heather A E Benson
Journal:  Pharmaceutics       Date:  2019-09-24       Impact factor: 6.321

6.  Optimization of entrapment efficiency and release of clindamycin in microsponge based gel.

Authors:  Alaa Khattab; Abdulhakim Nattouf
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.